Supply Status for Epipen

Supply Status for Epipen

June 21, 2019

Mylan’s manufacturing partner Meridian Medical Technologies, a subsidiary of Pfizer that manufactures EpiPen, has experienced recent manufacturing challenges which resulted in interruptions in the production of EpiPen 0.3mg and EpiPen Jr 0.15mg Adrenaline Auto-Injectors (AAIs).


To help manage product availability on an ongoing basis until a steady supply resumes, Mylan has assigned a prescription-only process for EpiPen 0.3mg, meaning patients can obtain up to a maximum of two EpiPen 0.3mg AAIs per prescription.


The prescription-only process does not affect EpiPen Jr 0.15mg.


Further details for patients, prescribers, pharmacists and schools can be found on the Epipen website.

More Latest News >

Stock Shortages

Dear Colleagues There will be limited supply of PPV23 vaccine during winter, until the next delivery expected in January 2020. ...

Latest Updates from PSNC

Click here to read the latest updates from PSNC.  You will find useful information around CPCS, PQS and lots more!

CPCF Checklist

Please see below a link to the PSNC CPCF Checklist which you may find useful.